MedPharm manufactures a range of semi-solid and liquid drug products including:
MedPharm’s manufacturing facilities were successfully inspected by the FDA in 2025, demonstrating the strength of our quality systems and readiness to support clinical and commercial manufacturing.
Inspection Outcomes:
MedPharm’s manufacturing operations are designed in alignment with U.S. FDA and global regulatory requirements, ensuring consistent quality across commercial programs. Our operations combine manufacturing expertise, process controls, and integrated analytical support to ensure reliable and compliant production.
Capabilities include:
MedPharm combines advanced infrastructure, technical expertise, and a quality-driven approach to support the manufacture of complex drug products. Our capabilities are designed to ensure efficiency, control, and reliability across a range of manufacturing requirements.
What we offer
MedPharm’s QC laboratories support analytical testing for potent products.
Capabilities include:
MedPharm works closely with pharmaceutical partners to support regulatory submissions and maintain compliance throughout the product lifecycle.
Capabilities include: